Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Legislation

This article was originally published in SRA

Executive Summary

Bill to reform Australia's Therapeutic Goods Act in parliament

Bill to reform Australia's Therapeutic Goods Act in parliament

The reform agenda drawn up by Australia's Therapeutic Goods Administration to streamline the regulatory framework for medical devices has been introduced in parliament1-3. The Therapeutic Goods Amendment (Medical Devices and Other Measures) Bill 2008, which was presented before the Senate on 3 December, amends the existing Therapeutic Goods Act 1989 in a number of ways.

The bill principally implements improvements that were identified during talks on the development of the Australia-New Zealand Therapeutic Products Authority, which is now on hold. The bill is the first in a package of reforms and will be followed by further legislative amendments.

The amendments expand the range of information that can be released to the public and provide a wider range of circumstances where the TGA can release information to Commonwealth agencies or international authorities to support safety and quality in therapeutic goods. It also offers clarity on the “fit and proper person” test that relates to grant of manufacturing licences with the aim of reducing unnecessary regulatory requirements.

The bill also allows the government, acting in the national interest, to exempt medical devices from the requirements of the act so that these products can be sourced from manufacturers who do not regularly supply goods to the Australian market, and do not have TGA approval. The provision allows the government to create a stockpile of devices, such as face masks and injection kits, for use in an emergency.

References

1. TGA, What's New: Regulatory Reform, 3 December 2008, www.tga.gov.au/regreform/index.htm#intro

2. Hansard, 3 December 2008, http://parlinfo.aph.gov.au/parlInfo/download/chamber/hansards/2008-12-03/toc_pdf/6446-2.pdf;fileType=application%2Fpdf#search=%22THERAPEUTIC%20GOODS%20AMENDMENT%20(MEDICAL%20DEVICES%20AND%20OTHER%20MEASURES)%20BILL%202008%22

3. The Regulatory Affairs Journal - Devices, 2008, 16(6), 405-406

Latest Headlines
See All
UsernamePublicRestriction

Register

PS114377

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel